Post-Study Procedures at Clinical Research Organizations (CROs)

What happens after a clinical trial is completed? The data and information collected are carefully reviewed by researchers at Celerion—one of the world's leading clinical research organizations (CROs)—alongside the partnering pharmaceutical or biotechnology company. This post-study analysis ensures all participant data is processed anonymously and securely to determine the next steps in medical research. The information collected about participants is anonymous, and individual participants are not identified. A decision is then made by the pharmaceutical or biotechnology company on how best to proceed with medical research. Many factors go into this decision, but it could not be made without the responsible efforts of our participants. If you have more questions about Clinical Research, please make sure to Contact Us. 

Frequently Asked Questions About Post-Trial Procedures

How do clinical research organizations (CROs) protect participant data after a study? At Celerion, all information collected about participants during the trial is kept entirely anonymous, and individual participants are never identified during the post-study review process.

How do pharmaceutical companies use the results from a CRO clinical trial? Following a study, the sponsoring pharmaceutical or biotechnology company reviews the data provided by the clinical research organization to decide how best to proceed with the medical research based on a variety of scientific factors.